{"pmid":32331519,"title":"Successful recovery of COVID-19 pneumonia in a patient from Colombia after receiving chloroquine and clarithromycin.","text":["Successful recovery of COVID-19 pneumonia in a patient from Colombia after receiving chloroquine and clarithromycin.","BACKGROUND: COVID-19 pandemics is a challenge for public health and infectious diseases clinicians, especially for the therapeutical approach that is not yet adequately defined. Amid this situation, investigational agents are being used, including chloroquine. We report here the clinical features and therapeutic course of the first reported patient with confirmed COVID-19 pneumonia that recovered in Colombia, after the use of chloroquine and clarithromycin. CASE PRESENTATION: A 34-year-old male, returning from Spain, presented with complaints of fever, and cough, and class-II obesity, being hospitalized. The respiratory viruses and bacteria tested by FilmArray((R)) PCR were negative. Two days later, clarithromycin was started because the patient was suspected as community-acquired pneumonia. At the third day, the rRT-PCR confirmed the SARS-CoV-2 infection. A day later, chloroquine was started because of that. His chest computed tomography was performed and showed bilateral multifocal ground-glass opacities with consolidation, which suggested viral pneumonia as a differential diagnosis. Progressively his clinical condition improved and at day 9, patient rRT-PCR for SARS-CoV-2 became negative. The patient was discharged and isolated at home per 14 days. CONCLUSIONS: Our patient improved significantly. This and other COVID-19 cases are urgently demanding results from clinical trials that support evidence-based therapeutical approaches to this pandemic and the clinical management of patients, especially those at critical care.","Ann Clin Microbiol Antimicrob","Millan-Onate, Jose","Millan, William","Mendoza, Luis Alfonso","Sanchez, Carlos Guillermo","Fernandez-Suarez, Hugo","Bonilla-Aldana, D Katterine","Rodriguez-Morales, Alfonso J","32331519"],"abstract":["BACKGROUND: COVID-19 pandemics is a challenge for public health and infectious diseases clinicians, especially for the therapeutical approach that is not yet adequately defined. Amid this situation, investigational agents are being used, including chloroquine. We report here the clinical features and therapeutic course of the first reported patient with confirmed COVID-19 pneumonia that recovered in Colombia, after the use of chloroquine and clarithromycin. CASE PRESENTATION: A 34-year-old male, returning from Spain, presented with complaints of fever, and cough, and class-II obesity, being hospitalized. The respiratory viruses and bacteria tested by FilmArray((R)) PCR were negative. Two days later, clarithromycin was started because the patient was suspected as community-acquired pneumonia. At the third day, the rRT-PCR confirmed the SARS-CoV-2 infection. A day later, chloroquine was started because of that. His chest computed tomography was performed and showed bilateral multifocal ground-glass opacities with consolidation, which suggested viral pneumonia as a differential diagnosis. Progressively his clinical condition improved and at day 9, patient rRT-PCR for SARS-CoV-2 became negative. The patient was discharged and isolated at home per 14 days. CONCLUSIONS: Our patient improved significantly. This and other COVID-19 cases are urgently demanding results from clinical trials that support evidence-based therapeutical approaches to this pandemic and the clinical management of patients, especially those at critical care."],"journal":"Ann Clin Microbiol Antimicrob","authors":["Millan-Onate, Jose","Millan, William","Mendoza, Luis Alfonso","Sanchez, Carlos Guillermo","Fernandez-Suarez, Hugo","Bonilla-Aldana, D Katterine","Rodriguez-Morales, Alfonso J"],"date":"2020-04-26T11:00:00Z","year":2020,"_id":"32331519","week":"202017|Apr 20 - Apr 26","doi":"10.1186/s12941-020-00358-y","keywords":["chloroquine","colombia","coronavirus disease 2019 (covid-19)","latin america","severe acute respiratory syndrome coronavirus 2 (sars-cov-2)"],"source":"PubMed","topics":["Case Report"],"weight":1,"locations":["Colombia","Spain","Colombia"],"countries":["Spain","Colombia"],"countries_codes":["ESP|Spain","COL|Colombia"],"e_drugs":["Clarithromycin","Chloroquine"],"_version_":1665071049689006080,"score":8.518259,"similar":[{"pmid":32157862,"pmcid":"PMC7161622","title":"CT Manifestations of Novel Coronavirus Pneumonia: A Case Report","text":["CT Manifestations of Novel Coronavirus Pneumonia: A Case Report","Background: Since December 2019, the outbreak of the novel coronavirus has impacted nearly >90,000 people in more than 75 countries. In this case report, we aim to define the chest computed tomography findings of 2019-novel coronavirus associated with pneumonia and its successful resolution after treatment. Case Report: A fifty-year-old female patient, who is a businesswoman, presented with chief complaints of \"fever for one week, diarrhea, anorexia, and asthenia.\" Initially, she was given Tamiflu. The influenza A virus serology was negative. Three days later, levofloxacin was started because the patient's symptoms did not improve. The novel coronavirus nucleic acid test was negative. It was noted that before the onset of the disease, the patient went to Wuhan on a business trip. Despite the given treatment, her body temperature rose to 39.2 degrees C and she was referred to our clinic for further evaluation. Then, chest computed tomography was performed and showed bilateral multifocal ground glass opacities with consolidation which suggested viral pneumonia as a differential diagnosis, and the subsequent 2019-novel coronavirus pneumonia nucleic acid test was positive. Conclusion: Chest computed tomography offers fast and convenient evaluation of patients with suspected 2019-novel coronavirus pneumonia.","Balkan Med J","An, Peng","Song, Ping","Lian, Kai","Wang, Yong","32157862"],"abstract":["Background: Since December 2019, the outbreak of the novel coronavirus has impacted nearly >90,000 people in more than 75 countries. In this case report, we aim to define the chest computed tomography findings of 2019-novel coronavirus associated with pneumonia and its successful resolution after treatment. Case Report: A fifty-year-old female patient, who is a businesswoman, presented with chief complaints of \"fever for one week, diarrhea, anorexia, and asthenia.\" Initially, she was given Tamiflu. The influenza A virus serology was negative. Three days later, levofloxacin was started because the patient's symptoms did not improve. The novel coronavirus nucleic acid test was negative. It was noted that before the onset of the disease, the patient went to Wuhan on a business trip. Despite the given treatment, her body temperature rose to 39.2 degrees C and she was referred to our clinic for further evaluation. Then, chest computed tomography was performed and showed bilateral multifocal ground glass opacities with consolidation which suggested viral pneumonia as a differential diagnosis, and the subsequent 2019-novel coronavirus pneumonia nucleic acid test was positive. Conclusion: Chest computed tomography offers fast and convenient evaluation of patients with suspected 2019-novel coronavirus pneumonia."],"journal":"Balkan Med J","authors":["An, Peng","Song, Ping","Lian, Kai","Wang, Yong"],"date":"2020-03-12T11:00:00Z","year":2020,"_id":"32157862","week":"202011|Mar 09 - Mar 15","doi":"10.4274/balkanmedj.galenos.2020.2020.2.15","keywords":["influenza","novel coronavirus pneumonia","pulmonary complications","computed tomography","diagnosis"],"source":"PubMed","topics":["Case Report"],"weight":1,"locations":["diarrhea","Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"e_drugs":["Levofloxacin","Oseltamivir"],"_version_":1664640874810703872,"score":457.83533},{"pmid":32266524,"title":"A case report of COVID-19 with false negative RT-PCR test: necessity of chest CT.","text":["A case report of COVID-19 with false negative RT-PCR test: necessity of chest CT.","The definite diagnosis of corona virus disease 2019 (COVID-19) is based on the viral isolation or positive result of polymerase chain reaction (PCR) from sputum, or nasal swab, or throat swab. However, the sensitivity to detect COVID-19 of real time (RT)-PCR is reported to be lower than that of chest CT. We report a case of 34-year-old man who was diagnosed as negative for COVID-19 based on the four sequential RT-PCR tests of his pharyngeal swab. Chest CT showed patchy ground-glass opacity on admission, and it rapidly progressed to segmental mixed consolidation and ground-glass opacity 3 days after admission, and it resolved in left upper lobe, but showed multifocal ground-glass opacities 7 days after admission, and they resolved within 2 weeks. The fifth RT-PCR test finally revealed positive results at the fifth day after admission. It is difficult to distinguish COVID-19 pneumonia from other viral pneumonia on CT findings alone; however, we emphasize the utility of chest CT to detect early change of COVID-19 in cases which RT-PCR tests show negative results.","Jpn J Radiol","Feng, Hao","Liu, Yujian","Lv, Minli","Zhong, Jianquan","32266524"],"abstract":["The definite diagnosis of corona virus disease 2019 (COVID-19) is based on the viral isolation or positive result of polymerase chain reaction (PCR) from sputum, or nasal swab, or throat swab. However, the sensitivity to detect COVID-19 of real time (RT)-PCR is reported to be lower than that of chest CT. We report a case of 34-year-old man who was diagnosed as negative for COVID-19 based on the four sequential RT-PCR tests of his pharyngeal swab. Chest CT showed patchy ground-glass opacity on admission, and it rapidly progressed to segmental mixed consolidation and ground-glass opacity 3 days after admission, and it resolved in left upper lobe, but showed multifocal ground-glass opacities 7 days after admission, and they resolved within 2 weeks. The fifth RT-PCR test finally revealed positive results at the fifth day after admission. It is difficult to distinguish COVID-19 pneumonia from other viral pneumonia on CT findings alone; however, we emphasize the utility of chest CT to detect early change of COVID-19 in cases which RT-PCR tests show negative results."],"journal":"Jpn J Radiol","authors":["Feng, Hao","Liu, Yujian","Lv, Minli","Zhong, Jianquan"],"date":"2020-04-09T11:00:00Z","year":2020,"_id":"32266524","week":"202015|Apr 06 - Apr 12","doi":"10.1007/s11604-020-00967-9","keywords":["covid-19, 2019 corona virus disease","ct, computed tomography","cxr, chest radiography","rt-pcr, real-time fluorescence polymerase chain reaction"],"source":"PubMed","topics":["Case Report"],"weight":1,"_version_":1664637636045701121,"score":352.4707},{"pmid":32247926,"pmcid":"PMC7129170","title":"Clinical features of the first cases and a cluster of Coronavirus Disease 2019 (COVID-19) in Bolivia imported from Italy and Spain.","text":["Clinical features of the first cases and a cluster of Coronavirus Disease 2019 (COVID-19) in Bolivia imported from Italy and Spain.","INTRODUCTION: In March 2020, Coronavirus Disease 2019 (COVID-19) arrived in Bolivia. Here, we report the main clinical findings, and epidemiological features of the first series of cases, and a cluster, confirmed in Bolivia. METHODS: For this observational, retrospective and cross-sectional study, information was obtained from the Hospitals and the Ministry of Health for the cases that were laboratory-diagnosed and related, during March 2020. rRT-PCR was used for the detection of the RNA of SARS-CoV-2 following the protocol Charite, Berlin, Germany, from nasopharyngeal swabs. RESULTS: Among 152 suspected cases investigated, 12 (7.9%) were confirmed with SARS-CoV-2 infected by rRT-PCR. The median age was 39 years (IQR 25-43), six of them male. Two cases proceed from Italy and three from Spain. Nine patients presented fever, and cough, five sore throat, and myalgia, among other symptoms. Only a 60 y-old woman with hypertension was hospitalized. None of the patients required ICU nor fatalities occurred in this group. CONCLUSIONS: This is the first report of surveillance of COVID-19 in Bolivia, with patients managed mainly with home isolation. Preparedness for a significant epidemic, as is going on in other countries, and the deployment of response plans for it, in the country is now taking place to mitigate the impact of the COVID-19 pandemic in the population.","Travel Med Infect Dis","Escalera-Antezana, Juan Pablo","Lizon-Ferrufino, Nicolas Freddy","Maldonado-Alanoca, Americo","Alarcon-De-la-Vega, Gricel","Alvarado-Arnez, Lucia Elena","Balderrama-Saavedra, Maria Alejandra","Bonilla-Aldana, D Katterine","Rodriguez-Morales, Alfonso J","32247926"],"abstract":["INTRODUCTION: In March 2020, Coronavirus Disease 2019 (COVID-19) arrived in Bolivia. Here, we report the main clinical findings, and epidemiological features of the first series of cases, and a cluster, confirmed in Bolivia. METHODS: For this observational, retrospective and cross-sectional study, information was obtained from the Hospitals and the Ministry of Health for the cases that were laboratory-diagnosed and related, during March 2020. rRT-PCR was used for the detection of the RNA of SARS-CoV-2 following the protocol Charite, Berlin, Germany, from nasopharyngeal swabs. RESULTS: Among 152 suspected cases investigated, 12 (7.9%) were confirmed with SARS-CoV-2 infected by rRT-PCR. The median age was 39 years (IQR 25-43), six of them male. Two cases proceed from Italy and three from Spain. Nine patients presented fever, and cough, five sore throat, and myalgia, among other symptoms. Only a 60 y-old woman with hypertension was hospitalized. None of the patients required ICU nor fatalities occurred in this group. CONCLUSIONS: This is the first report of surveillance of COVID-19 in Bolivia, with patients managed mainly with home isolation. Preparedness for a significant epidemic, as is going on in other countries, and the deployment of response plans for it, in the country is now taking place to mitigate the impact of the COVID-19 pandemic in the population."],"journal":"Travel Med Infect Dis","authors":["Escalera-Antezana, Juan Pablo","Lizon-Ferrufino, Nicolas Freddy","Maldonado-Alanoca, Americo","Alarcon-De-la-Vega, Gricel","Alvarado-Arnez, Lucia Elena","Balderrama-Saavedra, Maria Alejandra","Bonilla-Aldana, D Katterine","Rodriguez-Morales, Alfonso J"],"date":"2020-04-06T11:00:00Z","year":2020,"_id":"32247926","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.tmaid.2020.101653","keywords":["bolivia","coronavirus disease 2019 (covid-19)","epidemiology","latin america","severe acute respiratory syndrome coronavirus 2 (sars-cov-2)"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"locations":["Bolivia","Bolivia","Charite","Berlin","Germany","Italy","Spain","myalgia","Bolivia","Bolivia","Italy","Spain"],"countries":["Spain","Bolivia, Plurinational State of","Germany","Italy"],"countries_codes":["ESP|Spain","BOL|Bolivia, Plurinational State of","DEU|Germany","ITA|Italy"],"_version_":1664637850741637120,"score":344.13147},{"pmid":32238024,"pmcid":"PMC7157961","title":"A case of imported COVID-19 diagnosed by PCR-positive lower respiratory specimen but with PCR-negative throat swabs.","text":["A case of imported COVID-19 diagnosed by PCR-positive lower respiratory specimen but with PCR-negative throat swabs.","A 35-year-old woman presented with fever and mild diarrhoea without any respiratory symptoms 9 days after travelling to Japan from Wuhan, China. Her computed tomography scan revealed pneumonia. The first polymerase chain reaction (PCR) test on throat swab for the novel corona virus upon admission was negative. Therefore, she was treated for community-acquired pneumonia, but fever persisted. On hospital day 5, PCR test on induced sputum was positive, but a second polymerase chain reaction test on throat swab remained negative. She was discharged, fully recovered, on hospital day 12. A lower respiratory tract specimen should be obtained for better diagnosis of corona virus disease 2019, even in the absence of respiratory symptoms for patients with significant travel or exposure history.","Infect Dis (Lond)","Hase, Ryota","Kurita, Takashi","Muranaka, Emiri","Sasazawa, Hiroki","Mito, Haruki","Yano, Yudai","32238024"],"abstract":["A 35-year-old woman presented with fever and mild diarrhoea without any respiratory symptoms 9 days after travelling to Japan from Wuhan, China. Her computed tomography scan revealed pneumonia. The first polymerase chain reaction (PCR) test on throat swab for the novel corona virus upon admission was negative. Therefore, she was treated for community-acquired pneumonia, but fever persisted. On hospital day 5, PCR test on induced sputum was positive, but a second polymerase chain reaction test on throat swab remained negative. She was discharged, fully recovered, on hospital day 12. A lower respiratory tract specimen should be obtained for better diagnosis of corona virus disease 2019, even in the absence of respiratory symptoms for patients with significant travel or exposure history."],"journal":"Infect Dis (Lond)","authors":["Hase, Ryota","Kurita, Takashi","Muranaka, Emiri","Sasazawa, Hiroki","Mito, Haruki","Yano, Yudai"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32238024","week":"202014|Mar 30 - Apr 05","doi":"10.1080/23744235.2020.1744711","keywords":["coronavirus disease 2019 (covid-19)","real-time reverse transcription-polymerase chain reaction (rt-pcr) assay","the novel corona virus (sars-cov-2)"],"source":"PubMed","topics":["Case Report"],"weight":1,"locations":["Japan","Wuhan","China"],"countries":["China","Japan"],"countries_codes":["CHN|China","JPN|Japan"],"_version_":1664638354302435328,"score":309.14114},{"pmid":32321232,"title":"A man in his nineties with fever and dry cough.","text":["A man in his nineties with fever and dry cough.","BACKGROUND: COVID-19 can cause a fatal outcome in elderly patients, as this case report illustrates. CASE PRESENTATION: An active male in his nineties with a high level of function, despite several severe chronic diseases, was admitted to Oslo University Hospital after two days of fatigue, fever, dyspnoea and dry cough. He scored qSOFA 1 of 3 points due to high respiratory rate, and SIRS 2 of 4 points due to high respiratory rate and fever of 39.4 masculine C. PCR for influenza virus was negative and he received benzylpenicillin for pneumonia. The chest X-ray taken initially showed no lung affection. On day 5 after symptom debut he was tested for COVID-19 which was positive. He had not been travelling to high-risk areas or been exposed to any known confirmed COVID-19 patients. On the same day, a chest CT scan was performed that showed ground-glass opacities. In subsequent days the patient's health rapidly deteriorated. He developed irreversible respiratory failure with hypoxia without hypercapnia despite substantial oxygen support. Chest X-ray taken on disease day 7 showed progression of consolidations. The patient died 9 days after symptom debut. INTERPRETATION: This case illustrates a severe course of COVID-19 with fatal outcome. The patient was also one of the earliest admitted with COVID-19 in a Norwegian hospital and marked a new phase of the epidemic, as he had not been travelling to high-risk areas or been exposed to any confirmed COVID-19 patients.","Tidsskr Nor Laegeforen","Boren, Hakon Kinck","Kjostolfsen, Gjertrud Hole","Aalokken, Trond Mogens","Latif, Nadim","Brekke, Hanne","Lind, Andreas","Hesstvedt, Liv","32321232"],"abstract":["BACKGROUND: COVID-19 can cause a fatal outcome in elderly patients, as this case report illustrates. CASE PRESENTATION: An active male in his nineties with a high level of function, despite several severe chronic diseases, was admitted to Oslo University Hospital after two days of fatigue, fever, dyspnoea and dry cough. He scored qSOFA 1 of 3 points due to high respiratory rate, and SIRS 2 of 4 points due to high respiratory rate and fever of 39.4 masculine C. PCR for influenza virus was negative and he received benzylpenicillin for pneumonia. The chest X-ray taken initially showed no lung affection. On day 5 after symptom debut he was tested for COVID-19 which was positive. He had not been travelling to high-risk areas or been exposed to any known confirmed COVID-19 patients. On the same day, a chest CT scan was performed that showed ground-glass opacities. In subsequent days the patient's health rapidly deteriorated. He developed irreversible respiratory failure with hypoxia without hypercapnia despite substantial oxygen support. Chest X-ray taken on disease day 7 showed progression of consolidations. The patient died 9 days after symptom debut. INTERPRETATION: This case illustrates a severe course of COVID-19 with fatal outcome. The patient was also one of the earliest admitted with COVID-19 in a Norwegian hospital and marked a new phase of the epidemic, as he had not been travelling to high-risk areas or been exposed to any confirmed COVID-19 patients."],"journal":"Tidsskr Nor Laegeforen","authors":["Boren, Hakon Kinck","Kjostolfsen, Gjertrud Hole","Aalokken, Trond Mogens","Latif, Nadim","Brekke, Hanne","Lind, Andreas","Hesstvedt, Liv"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32321232","week":"202017|Apr 20 - Apr 26","doi":"10.4045/tidsskr.20.0218","source":"PubMed","topics":["Case Report"],"weight":1,"locations":["hypercapnia","Norwegian"],"countries":["Norway"],"countries_codes":["NOR|Norway"],"e_drugs":["Penicillin G"],"_version_":1664895932751151107,"score":279.20767}]}